Article

Mechanistic Basis for Inflammation and Tumor Promotion in Lungs of 2,6-Di- tert -butyl-4-methylphenol-Treated Mice: Electrophilic Metabolites Alkylate and Inactivate Antioxidant Enzymes

Department of Pharmaceutical Sciences, University of Colorado, Denver, Colorado, United States
Chemical Research in Toxicology (Impact Factor: 3.53). 03/2007; 20(2):199-207. DOI: 10.1021/tx060214f
Source: PubMed

ABSTRACT

An established model for mechanistic analysis of lung carcinogenesis involves administration of 3-methylcholanthrene to mice followed by several weekly injections of the tumor promoter 2,6-di-tert-butyl-4-methylphenol (BHT). BHT is metabolized to quinone methides (QMs) responsible for promoting tumor formation. QMs are strongly electrophilic and readily form adducts with proteins. The goal of the present study was to identify adducted proteins in the lungs of mice injected with BHT and to assess the potential impact of these modifications on tumorigenesis. Cytosolic proteins from treated mouse lungs were separated by two-dimensional electrophoresis, adducts detected by immunoblotting, and proteins identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Eight adducts were detected in the lungs of most, or all, of six experimental groups of BALB mice. Of these adducts, several were structural proteins, but others, namely, peroxiredoxin 6 (Prx6), Cu,Zn-superoxide dismutase (SOD1), carbonyl reductase, and selenium-binding protein 1, have direct or indirect antioxidant functions. When the 9000g supernatant fraction of mouse lung was treated with BHT-QM (2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone), substantial lipid peroxidation and increases in hydrogen peroxide and superoxide formation were observed. Studies with human Prx6 and bovine SOD1 demonstrated inhibition of enzyme activity concomitant with adduct formation. LC-MS/MS analysis of digests of adducted Prx6 demonstrated adduction of both Cys 91 and Cys 47; the latter residue is essential for peroxidatic activity. Analysis of QM-treated bovine SOD1 by matrix-assisted laser desorption/ionization time-of-flight MS demonstrated the predominance of a monoadduct at His 78. This study provides evidence that indicates Prx6, SOD1, and possibly other antioxidant enzymes in mouse lung are inhibited by BHT-derived QMs leading to enhanced levels of reactive oxygen species and inflammation and providing a mechanistic basis for the effects of BHT on lung tumorigenesis.

  • Source
    • "It is reported that cisplatin induced depletion of these enzymes due to loss of copper and zinc, which are essential for SOD activity or selenium, which is required for GSH-Px (Badary et al., 2005). Another possibility is that cisplatin directly binds to sulfhydryl groups on cysteine in SOD and GSH peroxidase causing diminished activity (Meier et al., 2007). Betaine supplementation prevented cisplatin-induced lipid peroxidation and protected against the decline in TAS and severe depletion of antioxidant enzymes in cisplatin-treated rats. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cisplatin is one of the most potent chemotherapeutic antitumor drugs used in the treatment of a wide range of solid tumors. Its primary dose-limiting side effect is nephrotoxicity. This study aims to investigate the effect of betaine supplementation on cisplatin-induced nephrotoxicity. A single intraperitoneal injection of cisplatin (5mg/kg) deteriorated the kidney functions as reflected by elevated blood urea nitrogen and serum creatinine levels. Oxidative/nitrosative stress was evident in cisplatin group by increased renal thiobarbituric acid-reactive substances (TBARS), an indicator of lipid peroxidation, reduced renal total antioxidant status and increased renal nitrite concentration. Cisplatin resulted in a decline in the concentrations of reduced glutathione, glutathione peroxidase, catalase, and superoxide dismutase in renal tissues. Renal tumor necrosis factor-α (TNF-α) was also elevated. Expressions of nuclear factor-kappa B (NF-κB) and caspase-3 were up-regulated in renal tissues as indicated by immunohistochemical analysis. Histopathological changes were observed in cisplatin group. Betaine supplementation (250mg/kg/day) orally via gavage for 21 days prior to cisplatin injection was able to protect against deterioration in kidney function, abrogate the decline in antioxidants enzymes and suppressed the increase in TBARS, nitrite and TNF-α concentrations. Moreover, betaine inhibited NF-κB and caspase-3 activation and improved the histological changes induced by cisplatin. Thus, the present study demonstrated the renoprotective nature of betaine by attenuating the pro-inflammatory and apoptotic mediators and improving antioxidant competence in kidney tissues of cisplatin treated rats. Betaine could be a beneficial dietary supplement to attenuate cisplatin nephrotoxicity. Copyright © 2014. Published by Elsevier GmbH.
    Full-text · Article · Dec 2014 · Experimental and toxicologic pathology: official journal of the Gesellschaft fur Toxikologische Pathologie
  • Source
    • "It is reported that cisplatin induced depletion of these enzymes due to loss of copper and zinc, which are essential for SOD activity or selenium, which is required for GSH-Px (Badary et al., 2005). Another possibility is that cisplatin directly binds to sulfhydryl groups on cysteine in SOD and GSH peroxidase causing diminished activity (Meier et al., 2007). Betaine supplementation prevented cisplatin-induced lipid peroxidation and protected against the decline in TAS and severe depletion of antioxidant enzymes in cisplatin-treated rats. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cisplatin is widely used in the treatment of solid tumors. Nevertheless, its full clinical utility is limited due to some adverse side effects including renal toxicity. This study aims to investigate the effect of betaine supplementation on the extent of tissue damage in cisplatin-induced nephrotoxicity. The animals were divided into four groups (n=8 per group): control, betaine, cisplatin (CDDP), and betaine + cisplatin. (1) saline control group; (2) cisplatin group in which rats were injected with a single intraperitoneal injection of cisplatin (5 mg/kg); (3) betaine group, in which betaine was given at a dose of (250 mg/kg/day) orally via gavage for 21 days; (4) cisplatin + betaine group in which betaine was given (250 mg/kg/day) orally via gavage for 21 days prior to cisplatin injection and daily for 5 days after cisplatin. At the end of experiments, the animals were sacrificed; blood and kidneys were collected. Nephrotoxicity was indicated by measuring blood urea nitrogen and serum creatinine levels. Renal content of malondialdehyde (MDA), an indicator of lipid peroxidation was elevated. The contents of internal antioxidants; reduced glutathione, glutathione peroxidase, catalase and superoxide dismutase were declined in renal tissues. Renal tumor necrosis factor-α (TNF- α) and caspase-3 were elevated in cisplatin-treated animals. Nuclear factor–kappa and caspase-3 were up-regulated in renal tissues as indicated by immunohistochemical analysis. Hisopathological changes were observed in cisplatin group. Betaine supplementation was able to protect against deterioration in kidney function, abrogate the decline in antioxidants enzymes and suppressed the increase in MDA and TNF- α concentrations. Moreover, betaine inhibited nuclear factor-kappa and caspase-3 activation and improved the histological changes induced by cisplatin. Betaine could be a beneficial dietary supplement to attenuate oxidative stress induced by cisplatin nephrotoxicity.
    Full-text · Conference Paper · Oct 2013
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The ingredients in the proposed Checkmate LBAM-F spray and the spray capsules are a health concern. Neither has been tested in humans. Some of the ingredients, individually, are know to be toxic to humans or animals. Butylated hydroxytoluene (BHT) and 2-hydroxy-4-n-octylbenzophenone are of particular concern. BHT is used in animal studies to induce lung damage and cancer in areas of the respiratory system that are reachable by the planned spray. BHT is activated into a more potent toxin and then cleared by the major detoxification enzymes cytochrome P450 and glutathione-S-transferase, which are variable in the population. 2 The effects of inhaled BHT in humans have not been studied. The benzophenone in the spray has not been tested but other benzophenones have been found to be stronger endocrine disturbers than bisphenol-A, a very concerning chemical. The capsule particle size and how it interacts in the human respiratory system is a known health hazard. 3,4 The urea particles in the spray can be expected to reach areas of the lung that can cause damage. Further, the particles and the chemicals they carry can cause damage in the nasal passages and more proximal respiratory tract.
    Preview · Article ·
Show more